H.U. Group Holdings, Inc. (the Company) today announced that it has resolved, at a meeting of the Board of Directors held on January 14, 2026, to change the Company’s Representative Executive Officer as described below.
1. Name and job titles of newly appointed Representative Executive Officer
Name |
New title |
Current title |
Goki Ishikawa |
Representative Executive Officer,
|
Managing Executive Officer |
2. Name and job titles of retiring Representative Executive Officer
Name |
New title |
Current title |
Shigekazu Takeuchi |
Director and Executive Officer |
Director, Representative Executive Officer, Chairman, President and Group CEO |
3. Reason for change
In May 2025, toward realizing its Vision for 2035, the Company announced its Medium-Term Management Plan “H.U. 2030” (MMP) as well as its CEO succession plan including the timing for the selection of the next CEO. As the succession plan progressed, the Company has recognized that Mr. Goki Ishikawa is the best to lead the execution of MMP as CEO considering he has made significant contributions to the growth of the H.U. Group as an Executive Officer in charge of IVD, which led to the resolution.
4. Career summary of newly appointed Representative Executive Officer
Name : Goki Ishikawa
Date of birth : November 18, 1976
Number of shares held : 20,100 shares (As of June 2025)
Career summary :
Mar. 1999 |
University of Tokyo, B.A. Economics |
Apr. 2000 |
Joined the Japan Defense Agency (currently Ministry of Defense, Japan) |
Jun. 2006 |
Harvard Business School, M.B.A. |
Sep. 2006 |
Joined the Boston Consulting Group |
Dec. 2008 |
Joined Elsevier |
Jan. 2012 |
Joined the Company |
Jun. 2013 |
Director, Fujirebio Diagnostics Inc. (incumbent) |
Apr. 2014 |
Director, FUJIREBIO INC. |
Jun. 2014 |
Director, Fujirebio Europe N.V. (incumbent) |
Mar. 2015 |
Representative Director, FUJIREBIO INC. |
Apr. 2016 |
Representative Managing Director, FUJIREBIO INC. |
Apr. 2017 |
Executive Vice President & Representative Director, FUJIREBIO INC. Executive Vice President & Representative Director, Fujirebio Holdings, Inc. |
Jun. 2018 |
President & CEO, FUJIREBIO INC. |
Jun. 2020 |
Executive Officer of the Company President & CEO, Fujirebio Holdings, Inc. (incumbent) Director, FUJIREBIO INC. (incumbent) |
Jun. 2023 |
Director, SRL, Inc. (incumbent) |
Jun. 2025 |
Managing Executive Officer of the Company (incumbent) |
5. Scheduled date of assuming office
April 1st, 2026
View source version on businesswire.com: https://www.businesswire.com/news/home/20260113958830/en/
The Company has recognized that Mr. Goki Ishikawa is the best to lead the execution of MMP as CEO considering he has made significant contributions to the growth of the H.U. Group as an Executive Officer in charge of IVD.
Contacts
For media:
Public Relations Section, Public Relations/Sustainability Dept.
Phone: +81-3-6279-0884
Email: pr@hugp.com
For investors and analysts:
IR/SR Dept.
Phone: +81-3-6279-0926
Email: ir@hugp.com
